Acelyrin announced that founder Shao-Lee Lin has stepped down as CEO and Mina Kim, Chief Legal and Administrative Officer, has been appointed CEO and to the company’s Board of Directors. Kim has served as Chief Legal and Administrative Officer since November 2022. Prior to that, she served as Chief Legal Officer and Head of Corporate Development at Zymergen. In addition to Kim’s appointment, Shephard Mpofu, who most recently served as SVP of Development, has been promoted to Chief Medical Officer, Gil Labrucherie, who serves as CFO, has been named Chief Business Officer in addition to CFO, and Sanam Pangali, who most recently served as SVP, Corporate Legal, has been promoted to Chief Legal Officer and Head of People.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLRN:
- ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
- ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024
- Acelyrin reports FY23 EPS ($5.43), consensus ($7.40)
- ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights
- Viridian Therapeutics price target lowered to $25 from $29 at B. Riley